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Aim To investigate if there is an association between 
M235T polymorphism of angiotensinogen gene and myo-
cardial infarction (MI) risk and perform a meta-analysis and 
an in silico approach.
Methods This case-control study included 340 partici-
pants (155 MI patients and 185 controls) examined at 
Kashan University of Medical Sciences (Kashan, Iran) be-
tween 2013 and 2015. Meta-analysis included 25 studies 
with 6334 MI patients and 6711 controls. Bioinformatics 
tools were applied to evaluate the impact of M235T poly-
morphism on angiotensinogen function and structure.
Results Genetic association study revealed a significant as-
sociation between TT genotype (odds ratio [OR] 2.08, 95% 
confidence interval [CI] 1.08-4.00, P = 0.029) and T allele (OR 
1.45, 95% CI 1.06-1.99, P = 0.021) and MI risk. Meta-analy-
sis also revealed a significant association between M235T 
polymorphism and MI risk in allelic (OR 1.55, 95% CI 1.10-
2.18, P = 0.012) and recessive (OR 1.69, 95% CI 1.13-2.53, 
P = 0.010) models within Asian population. In silico-analysis 
revealed that M235T fundamentally changed the function 
of angiotensinogen (score 32; expected accuracy 66%).
Conclusions Our study suggests that M235T polymor-
phism might be a helpful biomarker for screening of sus-
ceptible individuals for MI in Asian population.
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Myocardial infarction (MI) is a major cause of mortality, es-
pecially in industrial countries (1). Its predisposing factors 
are hyperlipidemia (2), smoking (3), diabetes (4), obesity (5), 
and hypertension (6), but its development may also be af-
fected by genetic factors (7,8). The key pathways involved 
in the MI development and progression are kallikrein-kinin 
and carbon metabolism pathways (9,10). Furthermore, de-
fects in renin-angiotensin-aldosterone system (RAAS) sys-
tem may result in the initiation and progression of vascular 
diseases. Angiotensinogen (AGT), one of the initial com-
ponents in this system, interacts with renin to produce 
angiotensin I, the pro-hormone of angiotensin II. Genetic 
variations in AGT gene modify the plasma concentration 
of AGT and may be implicated in the pathogenesis of hy-
pertension, coronary heart disease, and myocardial infarc-
tion (11,12). There is a common single nucleotide poly-
morphism (SNP) at location 803 (803 t > C; SNP ID: rs699) 
on exon 2 of the AGT gene. This transition results in sub-
stitution of methionine to threonine at codon 268, which 
is traditionally known as M235T. In recent years, several re-
searchers have investigated the association between AGT-
M235T polymorphism and MI, with inconsistent results 
(13-17). The aim of this study was to investigate the asso-
ciation between AGT-M235T polymorphism and MI risk us-




This case-control study included 340 participants: 155 pa-
tients with acute MI and 185 healthy controls. We screened 
about 250 patients with acute MI admitted to the Coro-
nary Care Unit of the Shahid Beheshti Hospital (Kashan, 
Iran) between 2013 and 2015. The mean age ± standard 
deviation of patients was 62.37 ± 3.21 years (range, 56-69 
years). Patients with the history of coronary artery (n = 23), 
vascular (n = 12), renal (n = 7), liver (n = 3), thyroid (n = 4), di-
abetes (n = 34), and any other familial and genetic diseases 
were excluded from the study. MI was confirmed by pa-
tient history, ECG changes, increased creatine kinase (CK)-
MB activity, and high levels of serum troponin (T or I). The 
controls were selected from people who referred to the 
same hospital for a routine check-up. The control group 
included 185 healthy participants without symptoms of 
coronary diseases and any other familial and genetic dis-
eases. Control participants were free from MI as shown by 
medical history, electrocardiography, and clinical examina-
tion. The mean age ± standard deviation of controls was 
61.68 ± 4.28 years (Table 1). 2 mL of blood was drawn from 
each participant and preserved in complete blood count 
tubes at -20°C until analysis. All participants gave a written 
informed consent. The study was approved by the Medi-
cal Research Ethics Committee of the Kashan University of 
Medical Sciences.
dNA extraction and sNP genotyping
We analyzed just one gene polymorphism (AGT-M235T) 
by polymerase chain reaction restriction fragment length 
polymorphism (PCR-RFLP) method. For this purpose, total 
genomic DNA was isolated from blood samples by DNG-
plus Kit (Cinnagen Co., Tehran, Iran). The primer sets used 
for amplification of AGT fragment were 5’-CCGTTTGTG-
CAGGGCCTGGCTCTCT-3’ and 5’-CAGGGTGCTGTCCACACT-
GGACCCC-3’. PCR was carried out in a total volume of 25 
µL, including 2.5 µL 10X PCR buffer, 0.5 U of Taq DNA poly-
merase, 1.5 µM MgCl
2, 0.5 µL dNTPs, 0.35 µM of each prim-
er, and 50 ng of template DNA (all PCR reagents were pur-
chased from Fermentas, Sankt Leon-Rot, Germany). PCR 
conditions were 94°C for 10 min, followed by 35 repetitive 
cycles of 94°C for 30 s, 59°C for 45 s, and 72°C for 60 s, with a 
final extension at 72°C for 10 min in a peqSTAR thermal cy-
cler (PeqLab, Erlangen, Germany). PCR products were then 
digested by PsyI restriction enzyme (Fermentas) at 37°C for 
16 h, electrophoresed on 8% polyacrylamide gel, and vi-
sualized by silver nitrate (AgNO3) staining as described by 
tABle 1. Participants’ demographic and biochemical characteristics
Variables Case (n = 155) Control (n = 185) P
Age (years), mean ± standard deviation  62.37 ± 3.21  61.68 ± 4.28 0.098
Sex (M/F) 102/53 127/58 0.642
Smoking (Y/N)  69/86  76/109 0.582
Body mass index (kg/m2), mean ± standard deviation  24.65 ± 2.44  24.41 ± 2.34 0.357
High density lipoprotein (mg/dL), mean ± standard deviation  42.40 ± 4.54  41.78 ± 4.29 0.196
Low-density lipoprotein (mg/dL), mean ± standard deviation 112.62 ± 18.91 115.30 ± 14.38 0.139
Triglycerides (mg/dL), mean ± standard deviation 133.13 ± 23.98 130.02 ± 25.03 0.246
Total cholesterol (mg/dL), mean ± standard deviation 138.48 ± 24.86 141.05 ± 23.31 0.328
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Green and Sambrook (18). Two fragments of 24-bp and 
141-bp were observed for 235TT genotype. A single band 
of 165-bp was characterized as 235MM genotype. Three 
fragments of 24-bp, 141-bp, and 165-bp were observed for 
235MT genotype. Finally, the accuracy of PCR-RFLP proce-
dure was confirmed by DNA sequencing (Cinnagen Co.).
Meta-analysis
Meta-analysis was conducted in accordance with the PRIS-
MA checklist (Supplementary Table 1) and included rele-
vant studies investigating the association between AGT-
M235T polymorphism and MI. PubMed, ScienceDirect, and 
Google Scholar were searched using the following key-
words: “angiotensinogen,” “AGT,” “M235T,” “polymorphism,” 
and “myocardial infarction.” Experimental studies were in-
cluded if they applied the following criteria: (i) investiga-
tion of the AGT-M235T polymorphism and MI (ii) in a case-
control study; (iii) on human beings; (iv) with accessible 
data to calculate the odds ratios (OR) and 95% confidence 
intervals (CI) (Table 2). The association between AGT-M235T 
polymorphism and MI was further stratified by ethnicity.
In silico analysis
The entire genomic sequence of human AGT gene was ob-
tained from Ensembl (Accession No. ENSG00000135744) 
and analyzed using GeneRunner software (Version 5.0.43 
Beta, Hastings Software, Hudson, NY, USA). The coding se-
quence of AGT gene was determined and translated to 
amino acid sequence by Expasy web server (web.expasy.
org/translate). The physicochemical properties of 235M 
normal and 235T mutant forms were obtained from Prot-
Param server (http://web.expasy.org/cgi-bin/protparam/
protparam). The impact of M235T substitution on the pro-
tein function was evaluated by SNAP (https://rostlab.org/
tABle 2. Characteristics of the studies included in the meta-analysis
Genotype frequencies Allele frequencies
Country
case control case control
(ethnicity) MM Mt tt MM Mt tt M t M t PhWe* Reference
France 229 301 100 258 372 111 759 501 888 594 0.219 Tiret et al 1995 (15)
Japan 6 31 66 10 41 52 43 163 61 145 0.647 Kamitani et al 1995 (13)
China 4 22 124 4 54 279 30 270 62 612 0.453 Ko et al 1997 (16)
Finland 48 66 37 53 64 34 162 140 170 132 0.088 Pastinen et al 1998 (17)
China 4 13 40 13 31 32 21 93 57 95 0.258 Chen et al 1998 (14)
UAE 14 18 8 16 26 19 46 34 58 64 0.256 Frossard et al 1998 (28)
Germany 319 582 157 385 585 222 1220 896 1355 1029 0.993 Gardemann et al 1999 (29)
Germany 38 54 30 28 53 11 130 114 109 75 0.064 Winkelmann et al 1999 (30)
Spain 69 99 52 64 96 40 237 203 224 176 0.713 Batalla et al 2000 (31)
Russia 63 85 50 43 75 34 211 185 161 143 0.905 Fomicheva et al 2000 (32)
Italy 63 124 60 54 76 27 250 244 184 130 0.976 Olivieri et al 2001 (33)
China 3 12 33 11 30 45 18 78 52 120 0.108 Xie et al 2001 (34)
Spain 59 121 32 34 97 49 239 185 165 195 0.252 Fernández-Arcás et al 2001 (35)
Turkey 32 48 22 39 59 16 112 92 137 91 0.340 Ermis et al 2002 (36)
USA 4 29 67 2 31 67 37 163 35 165 0.462 Hooper et al 2002 (37)
China 2 7 32 18 47 51 11 71 83 149 0.203 Zhu et al 2002 (38)
USA 71 98 39 215 349 153 240 176 779 655 0.608 Bis et al 2003 (39)
India 24 80 91 29 127 144 128 262 185 415 0.897 Ranjith et al 2004 (40)
England 212 252 83 197 226 82 676 418 620 390 0.208 Tobin et al 2004 (41)
China 2 10 35 13 26 31 14 80 52 88 0.087 Ren et al 2005 (42)
Brazil 46 52 12 43 51 10 144 76 137 71 0.356 Araujo et al 2005 (43)
Austria - - - - - - 1537 1203 832 634 - Renner et al 2005 (44)
Poland 30 46 24 22 44 29 106 94 88 102 0.503 Konopka et al 2011 (45)
Tunisia 29 53 41 53 61 30 111 135 167 121 0.117 Mehri et al 2011 (46)
Iran 42 79 34 71 85 29 163 147 227 143 0.672 This study
*PhWe – P value for hardy-Weinberg equilibrium.
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services/snap/) (19), PredictProtein (www.predictprotein.
org/getqueries) (20), and PolyPhen-2 (http://genetics.
bwh.harvard.edu/pph2/) (21). The effects of the substitu-
tion on the secondary structure of protein were assessed 
by Chou-Fasman method (http://fasta.bioch.virginia.edu/
fasta_www2/fasta_www.cgi?rm=misc1&pgm=cho). The 
three-dimensional structure of the AGT protein was ob-
tained from SNPeffect 4.0 server (http://snpeffect.switch-
lab.org/) (22) and visualized using Accelrys DS Visualizer 1.7 
program (http://accelrys.com/products/discovery-studio/
visualisation.php). The Kyte-Doolittle hydropathy pattern 
(23) was plotted using Accelrys DS Visualizer 1.7 program.
statistical analysis
Hardy-Weinberg equilibrium (HWE) was calculated using 
χ2 test. The association between the MI risk and AGT-M235T 
polymorphism was estimated using odds ratios (ORs) and 
their 95% confidence interval (CIs), which were calculated 
by binary logistic regression. Odds ratios were also adjust-
ed for age, sex, body mass index, smoking status, and bio-
chemical features. A two-tailed P-value lower than 0.05 was 
considered statistically significant. Statistical analyses were 
performed using SPSS software version 19.0 (SSPS Inc., IBM 
Corp Armonk, NY, USA).
In the meta-analysis, we first estimated the pooled OR and 
95% CI for the following five genetic models: T vs M (Al-
lelic), TT vs MM (co-dominant), TM vs MM (co-dominant), 
MT+TT vs MM (dominant), and TT vs MT+MM (recessive). 
Values of each study were combined by random effects 
model (24) or Mantel-Haenszel fixed effects (25). When the 
heterogeneity was significant (Pheterogeneity>0.1), the random 
effect model was used. Otherwise, the fixed effect mod-
el was used. For sensitivity analysis, each study at a time 
was excluded to detect the magnitude of the effect on 
the overall summary estimate. Begg’s funnel plot and Eg-
ger’s test were employed to evaluate the publication bias 
(26,27). The Open Meta Analyst (Tufts University, Medford, 
MA, USA; http://www.cebm.brown.edu/openmeta/) and 
Comprehensive Meta Analysis (Biostat, Inc., Englewood, 
NJ, USA; https://www.meta-analysis.com/) software were 
used for all calculations in the meta-analysis.
Results
distribution of AGt-M235t
The distribution of AGT-M235T genotypes was in Har-
dy-Weinberg equilibrium in the MI (χ2 = 0.076, P = 0.783) 
and control (χ2 = 0.179, P = 0.672) group. The genotypes 
and allele frequencies for the M235T in the MI and con-
trol group are shown in Table 3. The frequency of MM, MT, 
and TT genotypes in the MI group was 27.10%, 50.97%, 
and 21.93%, respectively, while these ratios in the control 
group were 38.38%, 45.94%, and 15.68%, respectively. The 
frequency of M and T alleles in the MI group was 52.58% 
and 47.42%, respectively, while these ratios in the control 
group were 61.35% and 38.65%, respectively. Genotype 
analysis revealed a significant association between TT gen-
otype and MI (OR 2.08, 95% CI 1.08-4.00, P = 0.029). Further-
more, T allele carriers (MT+TT) were at a high risk for MI de-
velopment (OR 1.70, 95% CI 1.05-2.75, P = 0.030). Also, we 
observed a significant association between T allele and MI 
risk (OR 1.45, 95% CI 1.06-1.99, P = 0.021).
Meta-analysis
215 articles were identified from electronic databases and 
the citations in potentially relevant articles. After reading 
abstracts and initial assessment of the articles, 42 and 141 
articles were found to be duplicates and irrelevant studies, 
respectively. From 32 potentially relevant reports, 24 stud-
ies from 17 countries were included in the meta-analysis 
(13-17,28-46). 3 reports were excluded because the full-
texts were not available (47-49). 3 other reports were ex-
tABle 3. Genotype and allele frequencies of M235t in cases and controls
No (%) unadjusted odds ratio Adjusted odds ratio*
Genotype/allele controls (n = 185) cases (n = 155) (95% confidence interval) P (95% confidence interval) P
MM  71 (38.38)  42 (27.10)    -   -    -   -
MT  85 (45.94)  79 (50.97) 1.57 (0.96-2.56) 0.070 1.59 (0.96-2.63) 0.073
TT  29 (15.68)  34 (21.93) 1.98 (1.06-3.70) 0.032† 2.08 (1.08-4.00) 0.029
MT+TT 114 (61.62) 113 (72.90) 1.68 (1.06-2.66) 0.029 1.70 (1.05-2.75) 0.030
M 227 (61.35) 163 (52.58)    -   -    -  -
T 143 (38.65) 147 (47.42) 1.43 (1.05-1.94) 0.022 1.45 (1.06-1.99) 0.021
*Adjusted oR – adjusted in multivariate logistic regression models including age, sex, body mass index, smoking status, and biochemical values.
†significant differences between the case and control groups are in bold.
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cluded because they were meta-analyses (50-52). 2 stud-
ies did not have accessible original data (53,54). Finally, 
the data from our case-control study was added to the 
meta-analysis. Therefore, 25 studies were included in the 
meta-analysis, including 6711 healthy controls and 6334 
patients with MI. Genotypes in all control groups were in 
Hardy-Weinberg equilibrium. Of the 25 studies, 9 studies 
involved Asian populations, 12 Caucasian, and 4 other eth-
nicities (Figure 1).
The meta-analysis of 25 studies showed a significant as-
sociation between M235T polymorphism and MI risk in 
allelic (OR 1.12, 95% CI 1.01-1.25, P = 0.033) and recessive 
(OR 1.24, 95% CI 1.03- 1.50, P = 0.025) models (Figure 2). In 
Asian population AGT-M235T was also associated with the 
MI risk in allelic (OR 1.55, 95% CI 1.10-2.18, P = 0.012) and re-
cessive (OR 1.69, 95% CI 1.13-2.53, P = 0.010) genetic mod-
els (Figure 2). Even, after the correction of the P-values for 
multiple testing by the Benjamini-Hochberg false discov-
ery rate method (55), AGT-M235T polymorphism was still 
significantly associated with the MI risk in Asian population 
(Supplementary Table 2). However, we observed no asso-
ciation between AGT-M235T and MI risk in any of the 5 ge-
netic models in Caucasian populations (Table 4).
FIGuRe 1. Flowchart of the study selection process.
tABle 4. Association results in the meta-analysis*
t vs M tt vs MM Mt vs MM Mt+tt vs MM tt vs MM+Mt
Group oR (95% CI) P oR (95% CI) P oR (95% CI) P oR (95% CI) P oR (95% CI) P
Total 1.12 (1.01-1.25) 0.033 1.17 (0.94-1.46) 0.162 1.03 (0.94-1.13) 0.540 1.06 (0.93-1.22) 0.355 1.24 (1.03-1.50) 0.025
Asian 1.55 (1.10-2.18) 0.012 1.72 (0.95-3.14) 0.076 1.15 (0.86-1.55) 0.352 1.41 (0.88-2.25) 0.152 1.69 (1.13-2.53) 0.010
Caucasian 1.01 (0.92-1.10) 0.864 1.01 (0.81-1.28) 0.892 1.02 (0.92-1.14) 0.664 1.00 (0.90-1.10) 0.941 1.04 (0.83-1.29) 0.761
*oR – odds ratio; CI – confidence interval.
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The heterogeneity test showed a true heterogene-
ity between studies in the T vs M (Pheterogeneity<0.001, 
I2 = 70%), TT vs MM (Pheterogeneity<0.001, I
2 = 62%), MT+TT 
vs MM (Pheterogeneity<0.024, I
2 = 40%), and TT vs MM+MT 
(Pheterogeneity<0.001, I
2 = 69%) genetic models (Table 5). Also, 
a publication bias was observed within total population 
in T vs M (PEgger = 0.002), TT vs MM (PEgger = 0.058), and TT 
vs MM+MT (PEgger = 0.015) genetic models. Meanwhile, we 
did not observe any publication bias in Asian population 
(PEgger>0.05). Also, the shape of the funnel plot showed 
no obvious evidence of asymmetry for Asian population 
(Figure 3). Sensitivity analysis was performed after elimi-
nation of one study at a time, and the result was robust 
(data not shown).
In silico results
The data from Protparam server revealed that the M235T 
substitution (Figure 4A) changed some physicochemical 
properties of AGT (Table 6). Grand average of hydropathici-
ty and instability index of the mutant protein were reduced 
after 235T substitution. Secondary protein structure analy-
sis predicted different secondary structure composition for 
two AGT variants. Indeed, Thr substitution in position 235, 
as part of sheet structure of the sequence, was altered to 
coil structure (Figure 4B). Hydrophobicity analysis revealed 
that M235T substitution caused a shift in hydrophobicity 
from 1.26 to 0.74 at residue of 235 (Figure 5A). Polyphen-2 
predicted AGT-M235T substitution as a benign mutation 
in both HumDiv and HumVar models (score, 0.001; sensi-
FIGuRe 2. Forest plot for the association of M235t polymorphism of angiotensinogen gene (AGT-M235t) with myocardial infarction (MI).
tABle 5. Results of heterogeneity and publication bias in the meta-analysis*
t vs M tt vs MM Mt vs MM Mt+tt vs MM tt vs MM+Mt
Group Ph I2 Pe Ph I2 Pe Ph I2 Pe Ph I2 Pe Ph I2 Pe
Total <0.001 70% 0.015 <0.001 62% 0.058 0.519 0% 0.543 0.024 40% 0.123 <0.001 69% 0.002
Asian <0.001 79% 0.087 0.003 65% 0.282 0.544 0% 0.846 0.031 53% 0.476 <0.001 73% 0.094
Caucasian  0.055 43% 0.665 0.012 56% 0.423 0.395 5% 0.132 0.387 6% 0.594  0.003 63% 0.123
*Ph – Pheterogeneity (P < 0.1 was considered as a significant difference); Pe – Pegger (P < 0.05 was considered as a significant difference).
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tivity: 0.99; specificity: 0.15). PredictProtein and SNAP serv-
ers revealed a significant effect of M235T substitution on 
the protein structure (score: 32; expected accuracy: 66%) 
(Figure 5B).
FIGuRe 3. Funnel plot for association of M235t polymorphism of angiotensinogen gene (AGT-M235t) with myocardial infarction 
(MI) in Asian population.
FIGuRe 4. M235t substitution and angiotensinogen (AGt) secondary structure. Representation of Met and thr residues in position 
235 (A&A’). secondary structure of AGt for 235M and 235t phenotypes in position 268 (B & B’).
tABle 6. Physico-chemical properties for 235M and 235t phenotypes of angiotensinogen protein
Protein phenotype Molecular weight theoretical pI* estimated half-life Instability index Aliphatic index GRAVY
235M 53154.2 Da 5.87 30 hours 41.16 99.77 0.065
235T 53124.1 Da 5.87 30 hours 40.99 99.77 0.059
*pI – isoelectric point; grand average of hydropathicity.
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dIsCussIoN
This study found TT genotype and T allele to be genetic 
risk factors for MI. To confirm this result, we also conducted 
a meta-analysis, which can more accurately determine the 
impact of a genetic polymorphism on the risk of diseas-
es development and progression (56). The meta-analysis 
found a statistically significant association between M235T 
with MI risk in both allelic and recessive models, but it also 
detected a significant heterogeneity between the stud-
ies. Studies in Japanese (13), Chinese (14), Italian (33), and 
Spanish (35) populations revealed a significant association 
between the AGT-M235T and MI. However, other studies 
did not observe this association (15-17). This inconsistency 
might partly be caused by the small sample sizes, especial-
ly in the case group, inappropriate for genetic association 
studies. Another cause may be ethnic and geographic vari-
ations. The meta-analysis for Asian populations revealed a 
significant association between AGT-M235T and the MI risk 
in 2 genetic models, but in 5 genetic models in Caucasian 
populations there was no significant association.
Different Asian populations also exhibited a great het-
erogeneity. For example, Chen et al (14), Zhu et al (38), 
and Ren et al (42), reported a significant associa-
tion between AGT-235T allele and MI risk, whereas Ko et 
al (16), Frossard et al (28), and Ranjith et al (40) did not 
observe this association. Such heterogeneity may influ-
ence the results of meta-analysis, which is why genetic 
association studies should be performed within one spe-
cific race and ethnicity.
There were 3 meta-analyses that reported erroneous data 
from the included studies (50-52). Sui and Gao (50) re-
ported no association between AGT-M235T and the MI 
risk, even in the subgroup analysis comprising different 
ethnic and control sources. However, they (50) included 
incorrect alleles and genotypes frequencies from 8 stud-
ies (29-32,36,39,40,43). Liang et al (51) and Wang and Pan 
(52) found an association between the polymorphism 
and MI risk in Asian population only. Liang et al (51), how-
ever, incorrectly presented the number of controls from 
the study of Gardemann et al (29) and the alleles and 
genotypes frequencies from the study of Hooper et al 
(37). Wang and Pan (52) incorrectly included two studies 
(37,39) as Caucasian. In our meta-analysis, all of these mis-
takes were corrected.
AGT gene variants were shown to be associated with hy-
pertension. Also, hypertensive patients with different AGT 
FIGuRe 5. hydrophobicity, PredictProtein, and sNAP predictions. the hydrophobicity plot for 235M and 235t phenotypes (A&A’). the 
PredictProtein and sNAP plots for M235t substitution, respectively (B’&B).
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variants showed significantly different plasma concentra-
tions of AGT (57). Thus, AGT variant could be a possible can-
didate for pharmacogenomic renin-angiotensin system 
blockage intervention (58).
Amino acid substitutions are a common cause of the 
development of human inherited diseases (59). There-
fore, detection of non-synonymous single nucleotide 
polymorphisms, which lead to amino acid substitutions 
is essential for understanding the molecular aspects of 
diseases. A computational analysis of mutations with 
subsequent alteration in protein function and structure 
would be beneficial in ranking the disease-causing SNPs 
with the consequent disorders (60). In this study, we eval-
uated the effects of M235T substitution on AGT protein 
by in silico tools such as ProtParam, SNAP, PredictProtein, 
and PolyPhen-2 servers. ProtParam calculates numerous 
physico-chemical properties inferred from a protein se-
quence without giving any additional information. Poly-
Phen2 scoring makes it possible to determine the effects 
of SNPs on protein phenotypes. It requires input data 
such as location and variety of amino acid substitution 
(40). SNAP, as a neural-network based tool, assesses the 
impact of amino acid changes on proteins. SNAP server 
uses different biophysical features of the substitution in 
order to predict the impact of mutation on protein func-
tion (38). Although our data from PolyPhen2 recognized 
M235T substitution as a benign mutation, other in silico 
analyses revealed this substitution as a mutation affect-
ing physicochemical properties, secondary structure, and 
AGT function.
There are some limitations of our study. In the case-control 
study, we set the lower age limit for study entry, although 
cases with earlier disease onset should also be considered. 
In addition, we did not evaluate factors such as epigenet-
ics, other genes, other mutations, and environmental fac-
tors, which may modulate the effects of AGT-M235T poly-
morphism on MI. In the meta-analysis, there was a lack of 
data from African populations. Second, a lack of original 
data from the studies included in the meta-analysis re-
stricted further evaluations of the potential interactions 
that may modulate MI risk, such as gene-environment 
and gene-gene.
In conclusion, data from the genetic association study re-
vealed that M235T substitution in AGT might be a genetic 
risk factor for MI, especially in Asian population. Also in sil-
ico analysis revealed that this substitution may affect the 
AGT structure and function. Future studies in larger popu-
lations should assess epigenetics, other genes, other muta-
tions, and environmental factors.
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